Atrial Flutter Clinical Trials

A listing of Atrial Flutter medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alaska

Anchorage Alaska 99508

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Arizona

Phoenix Arizona 85018

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Phoenix Arizona 85004

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

California

UPDATED

La Jolla California 92037

A clinical research study of Amigo™ Robotic Catheter Manipulation and Manual Catheter Manipulation for the treatment of Atrial Fibrillation or Atrial Flutter

East Palo Alto California 94303

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Loma Linda California 92357

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Pasadena California 91105

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Sacramento California 95816

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Colorado

Aurora Colorado 80045

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Denver Colorado 80120

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Florida

University of South Florida - South Tampa Center for Advanced Healthcare
Tampa Florida 33606

GENETIC-AF: A Genotype-Directed Comparative Effectiveness Trial of Bucindolol and Toprol-XL for Prevention of Symptomatic Atrial Fibrillation/Atrial Flutter in Patients with Heart Failure

View More ▼

Miami Florida 33136

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Tampa Florida 33606

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Georgia

Athens Georgia 30606

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Atlanta Georgia 30322

A clinical trial to evaluate treatments using Catheter ablation for patients with Atrial Flutter or Arrhythmia

Illinois

Gurnee Illinois 60031

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Oakbrook Terrace Illinois 60181

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Indiana

Hammond Indiana 46320

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Indianapolis Indiana 46260

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Iowa

Iowa City Iowa 52242

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Michigan

Royal Oak Michigan 48703

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Ypsilanti Michigan 48197

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Minnesota

Minneapolis Minnesota 55417

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

St. Paul Minnesota 55102

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Missouri

St. Louis Missouri 63110

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Nebraska

Lincoln Nebraska 68506

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Omaha Nebraska 68198

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

New Jersey

Elmer New Jersey 08318

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

New York

Albany New York 12205

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

North Carolina

Durham North Carolina 27705

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Greensboro North Carolina 27401

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Ohio

Akron Ohio 44304

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Cleveland Ohio 44106

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Columbus Ohio 43210

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Oklahoma

Oklahoma City Oklahoma 73120

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Oregon

Portland Oregon 97201

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Pennsylvania

Hershey Pennsylvania 17033

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Lancaster Pennsylvania 17603

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Philadelphia Pennsylvania 19104

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Pittsburgh Pennsylvania 15212

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Tennessee

Jackson Tennessee 38305

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Nashville Tennessee 37232

A clinical research study of dabigatran etexilate mesylate for the treatment of Atrial Fibrillation or Atrial Flutter

Nashville Tennessee 37232

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Texas

Austin Texas 78705

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Utah

Salt Lake City Utah 84132

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Virginia

Norfolk Virginia 23507

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Washington

Puyallup Washington 98372

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Belgium

Aalst 9300

Patients are needed to participate in a clinical research study of PolarStart System to evaluate Atrial Flutter

Canada

Calgary Alberta T2N 4Z6

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Cambridge Ontario N1R 6V6

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter